Abstract:
A method and system for receiving magnetic resonance signals, and a magnetic resonance imaging system are provided. The method includes dividing coil units in a receiving coil array into different coil unit groups. For each of the coil unit groups, correlations are established between carrier frequencies and the signals received by each coil unit in the coil unit group. Low noise amplification is performed, and filtering and frequency mixing is performed on the signals received by all the coil units in the coil unit group according to the correlations to obtain intermediate frequency signals borne on the respectively corresponding carrier frequencies of an identical channel. After performing amplification and filtering on the intermediate frequency signals, the intermediate frequency signals are output to an analog-to-digital conversion unit to perform digital sampling so as to obtain digital domain signals.
Abstract:
The present invention relates to certain tricyclic derivatives which are capable of inhibiting histone deacetylases. The compounds of this invention are therefore useful in treating diseases associated with abnormal histone deacetylase activities. Pharmaceutical compositions comprising these compounds, methods of treating diseases utilizing pharmaceutical compositions comprising these compounds, and methods of preparing these compounds are also disclosed.
Abstract:
The present invention relates to 2-indolinone derivatives which are capable of inhibiting protein kinases and histone deacetylases. The compounds of this invention are therefore useful in treating diseases associated with abnormal protein kinase activities or abnormal histone deacetylase activities. Pharmaceutical compositions comprising these compounds, methods of treating diseases utilizing pharmaceutical compositions comprising these compounds, and methods of preparing these compounds are also disclosed.
Abstract:
Provided herein are isolated compounds of formula 1: processes for their preparation and isolation, as well as pharmaceutical compositions which comprise these therapeutic agents, and methods of use therefore the treatment and/or control of conditions associated with or mediated by effects of histone deacetylase.
Abstract:
A receiver of a magnetic resonance imaging system and a magnetic resonance imaging system are provided. The receiver includes a receiving end for receiving an analog magnetic resonance signal from a local coil of the magnetic resonance imaging system, a sending end for sending a digital magnetic resonance signal to an image reconstruction apparatus of the magnetic resonance imaging system, at least two digital processing channels connected to the sending end for digitizing the analog magnetic resonance signal to the digital magnetic resonance signal, and a channel selection unit connected between the digital processing channels and the receiving end for selecting a corresponding digital processing channel from the digital processing channels according to type information about the local coil. The embodiments may be compatible with many types of local coils without re-designing the local coils, which significantly reduces the cost of the system.
Abstract:
An RF coil device and an MM apparatus allowing a connection relationship between input RF channels and output RF channels to be controlled by a smaller number of switch elements are provided. The RF coil device includes multiple coil segments and a multi-selection switch. Input terminals of the multi-selection switch are each connected to a different coil segment. An output terminal of the multi-selection switch leads to an RF output channel. A control terminal of the multi-selection switch is used to receive a control signal so as to select a coil segment for connection to the output terminal. Multiple coil segments connected to the input terminals are not in consecutive positions, and the number of coil segments by which any two of the multiple coil segments are spaced apart is no fewer than the maximum number of coil segments required for one MRI imaging less 1. The MRI apparatus includes the RF coil device.
Abstract:
The present invention relates to 2-indolinone derivatives which are capable of inhibiting protein kinases and histone deacetylases. The compounds of this invention are therefore useful in treating diseases associated with abnormal protein kinase activities or abnormal histone deacetylase activities. Pharmaceutical compositions comprising these compounds, methods of treating diseases utilizing pharmaceutical compositions comprising these compounds, and methods of preparing these compounds are also disclosed.
Abstract:
Provided herein are isolated compounds of formula I: processes for their preparation and isolation, as well as pharmaceutical compositions which comprise these therapeutic agents, and methods of use therefore the treatment and/or control of conditions associated with or mediated by effects of histone deacetylase.
Abstract:
A method and system for receiving magnetic resonance signals, and a magnetic resonance imaging system are provided. The method includes dividing coil units in a receiving coil array into different coil unit groups. For each of the coil unit groups, correlations are established between carrier frequencies and the signals received by each coil unit in the coil unit group. Low noise amplification is performed, and filtering and frequency mixing is performed on the signals received by all the coil units in the coil unit group according to the correlations to obtain intermediate frequency signals borne on the respectively corresponding carrier frequencies of an identical channel. After performing amplification and filtering on the intermediate frequency signals, the intermediate frequency signals are output to an analog-to-digital conversion unit to perform digital sampling so as to obtain digital domain signals.
Abstract:
The present invention relates to certain tricyclic derivatives which are capable of inhibiting histone deacetylases. The compounds of this invention are therefore useful in treating diseases associated with abnormal histone deacetylase activities. Pharmaceutical compositions comprising these compounds, methods of treating diseases utilizing pharmaceutical compositions comprising these compounds, and methods of preparing these compounds are also disclosed.